Sustained Inhibition of Oxidized Low-Density Lipoprotein Is Involved in the Long-Term Therapeutic Effects of Apheresis in Dialysis Patients | Zendy

Yuko TsurumiIkeya | Zendy; Kouichi Tamura | Zendy; Koichi Azuma | Zendy; Hiroshi Mitsuhashi | Zendy; Hiromichi Wakui | Zendy; Ichiro Nakazawa | Zendy; Teruyasu Sugano | Zendy; Yasuyuki Mochida | Zendy; Toshiaki Ebina | Zendy; Nobuhito Hirawa | Zendy; Yoshiyuki Toya | Zendy; Kazuaki Uchino | Zendy; Satoshi Umemura | Zendy

Open Access

Sustained Inhibition of Oxidized Low-Density Lipoprotein Is Involved in the Long-Term Therapeutic Effects of Apheresis in Dialysis Patients

Author(s) -

Yuko TsurumiIkeya,

Kouichi Tamura,

Koichi Azuma,

Hiroshi Mitsuhashi,

Hiromichi Wakui,

Ichiro Nakazawa,

Teruyasu Sugano,

Yasuyuki Mochida,

Toshiaki Ebina,

Nobuhito Hirawa,

Yoshiyuki Toya,

Kazuaki Uchino,

Satoshi Umemura

Publication year - 2010

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.109.200212

Subject(s) - apheresis , medicine , ldl apheresis , fibrinogen , hemodialysis , endothelium , umbilical vein , lipoprotein , nitric oxide , dialysis , brachial artery , endothelial stem cell , gastroenterology , immunology , cardiology , blood pressure , cholesterol , platelet , in vitro , chemistry , biochemistry

Low-density lipoprotein (LDL) apheresis is a potential therapy for conventional therapy-resistant peripheral artery disease. In the present study, we examined the chronic effects of LDL apheresis on clinical parameters in vivo and endothelial cell functions in vitro in hemodialysis patients who had the complication of peripheral artery disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research